Back

Tau Ablation Rewires Brain Cell Programs in Health and Restores Function in Disease

Chimal-Juarez, E.; Patel, H.; Jury-Garfe, N.; Dabin, L. C.; Vidal, R.; Kim, J.; Lasagna-Reeves, C. A.

2026-05-17 neuroscience
10.64898/2026.05.12.724684 bioRxiv
Show abstract

Tau is a microtubule-associated protein with diverse roles in the healthy brain but contributes to neurodegenerative disorders when dysregulated. Although tau ablation has shown protective effects in several disease models, how its absence confers this protection remain unclear. Here, we performed and analyzed single-nucleus RNA sequencing on cortices of aged tau knockout (Mapt-/-) mice in a wild type background as well as in a vascular amyloid model to evaluate the effect on disease context. Comparisons in a wild type setting revealed that tau ablation induced compensatory remodeling across multiple cell types. Excitatory neurons expanded into a distinct subtype with unique glutamatergic signaling, astrocytes adopted synaptoprotective states, oligodendrocytes upregulated genes supporting connectivity and plasticity, and microglia engaged structural remodeling programs. In contrast, in disease, tau removal not only restored functions disrupted by vascular amyloid pathology, but also generated new phenotypes. Excitatory neurons rewired receptor and postsynaptic signaling, astrocytes and oligodendrocytes recovered wild-type-like gene programs related to neurotransmitter cycling, synaptic support, and myelin integrity, and microglia reprogrammed toward sensing and mounting responses. Together, these findings demonstrate that tau ablation reshapes brain cellular programs in a context-dependent manner, exerting adaptive responses in the otherwise healthy brain while restoring homeostatic functions under vascular amyloid pathology. These results position tau as a key regulator of neuronal-glial network balance and highlight the importance of understanding how tau influences distinct cellular programs within specific disease environments.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Neuron
282 papers in training set
Top 0.1%
25.6%
2
Nature Communications
4913 papers in training set
Top 21%
9.1%
3
Nature Neuroscience
216 papers in training set
Top 0.9%
9.1%
4
Cell Reports
1338 papers in training set
Top 7%
6.3%
50% of probability mass above
5
Immunity
58 papers in training set
Top 0.9%
6.3%
6
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 21%
3.6%
7
Alzheimer's & Dementia
143 papers in training set
Top 1%
3.0%
8
Science
429 papers in training set
Top 11%
2.7%
9
eLife
5422 papers in training set
Top 34%
2.3%
10
Developmental Cell
168 papers in training set
Top 7%
2.1%
11
Cell
370 papers in training set
Top 9%
2.1%
12
Brain
154 papers in training set
Top 3%
1.8%
13
Acta Neuropathologica
51 papers in training set
Top 0.7%
1.7%
14
Science Advances
1098 papers in training set
Top 22%
1.3%
15
PLOS Biology
408 papers in training set
Top 13%
1.3%
16
Nature Genetics
240 papers in training set
Top 6%
1.2%
17
Molecular Cell
308 papers in training set
Top 8%
1.2%
18
The Journal of Neuroscience
928 papers in training set
Top 7%
1.2%
19
Nature Metabolism
56 papers in training set
Top 2%
1.2%
20
Advanced Science
249 papers in training set
Top 15%
1.1%
21
Journal of Experimental Medicine
106 papers in training set
Top 4%
0.8%
22
Molecular Neurodegeneration
49 papers in training set
Top 0.8%
0.8%
23
Aging Cell
144 papers in training set
Top 3%
0.7%
24
The EMBO Journal
267 papers in training set
Top 5%
0.7%
25
Science Translational Medicine
111 papers in training set
Top 7%
0.6%